Herasight
Advanced Genetic Screening
- Employees
- 1–10
- Business Model
- B2C
- Website
- herasight.com
- Total Funding
- $3.0M
- Last Round
- $3.0M SeedJan 2024
- Rounds
- 1
About
Genetics startup building high-quality genetic tests for families, including IVF outcome prediction and disease risk assessment for embryos.
Summary
Herasight is a Biotech company. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Jan 2024. Investors include Lux Capital, Amplo and IA Ventures.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...